GRIFOLS reported €1.92B in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Alcon AG ALC:SW 2.38B 172M
Amadeus IT AMS:SM € 1737.4M 691M
Amarin AMRN:US $ 364.74M 5.69M
AstraZeneca AZN:LN 23649M 1427M
Bayer BAYN:GR € 28727M 801M
Ferrovial FER:SM € 8076M 650M
Fresenius FRE:GR € 15352M 148M
Fresenius Medical Care FME:GR € 7492M 67.37M
Galapagos GLPG:NA € 575.49M 1.49M
Genmab GEN:DC DK 1830M 479M
GlaxoSmithKline GSK:LN 22417M 1030M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 9.08B 646M
Hikma Pharmaceutical HIK:LN 960M 68M
Inditex ITX:SM € 9678M 1538M
Merck MRK:GR € 9793M 27M
Novartis NOVN:VX SF 29880M 247M
William Demant Holding WDH:DC 9.47B 2.1B